Objectives: To detect the occurrence of low susceptibility to colistin (polymyxin E), a last-resort antimicrobial, among enterobacteria isolated from samples of animal origin (poultry and swine) and to find out the molecular basis of colistin resistance.
Introduction
Polymyxins are cyclic pentapeptides, covalently bonded to a fatty acid chain, with strong antimicrobial activity against Gramnegative bacteria. 1 The bactericidal action of polymyxins is mediated by their binding to the negatively charged lipopolysaccharide of the external membrane. Products of pmr (polymyxin resistance) genes promote the covalent modification of lipopolysaccharide, reducing the attachment of polymyxins to the external surface of Gram-negative bacteria. 1 Since resistance to these antimicrobials is a rare event, polymyxin B and especially polymyxin E (colistin) are considered treatments of last resort against multidrug-resistant strains frequently found among nosocomial pathogens such as Klebsiella, Pseudomonas, Acinetobacter, Enterobacter and Escherichia coli. 2 The genes pmrB and pmrA encode a two-component system with a sensor histidine kinase (PmrB) and its cognate regulator (PmrA), which, once phosphorylated, activates the expression of pmr genes. 3 In vitro selection with colistin has been used to isolate mutants of PmrA and PmrB with up-regulated expression of pmr genes and colistin resistance in Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa and Acinetobacter baumannii. 4 -6 Moreover, polymorphisms of PmrA and/or PmrB of A. baumannii and Klebsiella pneumoniae have been detected in clinical isolates as well as after colistin treatment of human patients. 7 -10 Epidemiological surveillance of enterobacteria isolated worldwide from humans has provided evidence that colistin resistance remains low among E. coli (0.2%) and K. pneumoniae (1.5%), with no sign of an increase during 2006-09. 11 Similarly, the prevalence of colistin resistance is low among isolates from animals, although there are exceptions, especially in clinical isolates from pigs in some countries. 1 The fact that administration of colistin has become a regular practice in the treatment of colibacillosis 
Materials and methods
Isolates tested were recovered from surveillance programmes through the Spanish Surveillance Network of Antimicrobial Resistance in Bacteria of Veterinary Origin (VAV Network) and surveillance programmes for food of animal origin. 12 Enterobacteria were isolated from eggs (sampled at retail, taken from different supermarkets) and swine samples (faeces from fattening pigs at slaughterhouses). MICs of antimicrobials were determined by using the 2-fold broth microdilution reference method according to ISO 20776-1:2006. The threshold of antimicrobial resistance adopted in this work was based on the epidemiological cut-off (ECOFF) values recommended by EUCAST (http://www.eucast.org).
The coding sequences of the pmrA and pmrB genes were amplified from crude DNA samples prepared by boiling cells in water. After centrifugation, the supernatant was used directly for PCR reactions with primers already described for Salmonella 13 or with primers designed for E. coli pmrA [forward 5
′ -AGTTTTCCTCATTCGCGACCA and reverse 5 ′ -TACCAGGC TGCGGATGATATTCT (product of 714 bp)] and E. coli pmrB [forward 5
′ -GGATGGCCTGATGTGACGCTGTC and reverse 5 ′ -GCGCGGCTTTGGCTATA TGCTG (1312 bp)], by using annealing and extension at 688C. DNA fragments were purified from gels (Intron Biotechnology, Seongnam, South Korea) and sequenced by the STAB service of the University of Extremadura (Spain). Bioinformatics tools used in this work are publicly available at the web platforms of the NCBI (National Center for Biotechnological Information), EBI (European Bioinformatics Institute) and SMS (Sequence Manipulation Suite). 14 
Results

Bacterial screening and antimicrobial resistance
Enterobacteria isolated from eggs and swine samples were screened for colistin resistance using the ECOFF value defined by EUCAST (colistin MIC .2 mg/L; http://www.eucast.org). In these samples, taken during 2009 -13, nine bacteria whose MICs of colistin were higher than ECOFF were detected (Table 1) , seven corresponding to S. enterica (2.6% of total Salmonella isolates) and two to E. coli (0.4%). Susceptibility to other antimicrobials revealed that colistin resistance was not linked to a multidrug resistance phenotype, since only the E. coli isolate ZTA13/02182 presented the penta-resistant phenotype (ampicillin, chloramphenicol, streptomycin, sulfamethoxazole and tetracycline), plus resistance to ciprofloxacin, gentamicin and kanamycin (Table 2 ). In contrast, the three Salmonella Enteritidis isolates shared only, in addition to colistin, low susceptibility to ciprofloxacin ( Table 2) .
Polymorphism of pmrA and pmrB sequences among colistin-resistant isolates
The coding sequences of the pmrA and pmrB genes were determined in bacteria screened for colistin resistance (Table 1) , in the nine colistin-resistant (Table 2 ) plus nine randomly selected colistin-susceptible strains (colistin MIC ,2 mg/L), including one S. enterica isolated in 2013 (ZTA13/1700) and eight E. coli from 2011 (ZTA11/0606, ZTA11/1357, ZTA11/1860 and ZTA/2612) and 2013 (ZTA13/0455, ZTA13/1067, ZTA13/1622 and ZTA13/ 2284). The eight S. enterica isolates, seven colistin-resistant strains ( Table 2 ) and one colistin-susceptible strain shared a total of 12 polymorphic positions that were all synonymous at the protein level (not shown). Moreover, PmrA and PmrB sequences deduced from S. enterica isolates in this work did not present any of the protein polymorphisms detected after in vitro selection of colistin-resistant strains in S. enterica.
13 By contrast, seven out of the 22 polymorphisms detected in pmrA and pmrB coding sequences from the 10 E. coli isolates, two colistinresistant (Table 2 ) and seven colistin-susceptible strains, were non-synonymous ( Figure S1 , available as Supplementary data at JAC Online). Among these, polymorphisms that produce protein variants 144G S (PmrA), 283D G (PmrB) and 357Y N (PmrB) were found only in colistin-susceptible strains ( Figure S1 ) and did not match any mutation previously detected after in vitro selection with colistin. 13 Moreover, none of the three non-synonymous polymorphisms found between the two colistin-resistant E. coli strains (Table 2) had previously been described in E. coli, as evidenced by BLASTn comparison against the sequence database no./nt (nucleotide collection, NCBI). Remarkably, two of the mutations uniquely found in colistin-resistant E. coli strains, 81R S of PmrA and 161V G of PmrB, have also been found after in vitro selection of S. enterica colistin-resistant strains. 13 
Discussion
The fact that mutations of the PmrAB two-component sensorregulator might confer polymyxin resistance on Gram-negative bacteria is a matter of the highest clinical relevance. 1 However, despite exhaustive surveillance, enterobacteria presenting such polymorphisms had not been detected in nature before the present work, although a recent exception is represented by K. pneumoniae strains recovered from a human patient treated with colistin. 11 Interestingly, among the 27 residues affected by nonsynonymous polymorphisms that were found after in vitro selection of colistin-resistant strains in Salmonella, 13 positions R81 of PmrA and V161 of PmrB were also found mutated in non-clinical isolates of E. coli from swine faeces analysed in this work ( Table 2) . None of these two mutations has been detected before in Quesada et al.
sequences from E. coli, even though .1000 pmrA and pmrB sequences from these bacteria are available for comparison. Considering that colistin resistance in E. coli occurs at extremely low frequency (www.eucast.org), most if not all E. coli pmrAB sequences deposited in databases would represent colistinsusceptible strains (with the exception of strains ZTA11/01748 and ZTA13/02182 in the present work), and thus the link found between the mutations and colistin resistance should be considered a highly significant association, although it was not observed for colistin resistance of S. enterica isolated in this work. Accordingly, colistin resistance in Salmonella spp. has recently been shown independently of PmrAB polymorphism in a large screening of bacteria from different environments, including samples from animals and their products, where it was shown that some genetic backgrounds, such as serovar Enteritidis, might express levels of colistin resistance even higher than the recommended ECOFF of 2 mg/L. 15 Although the 81R S polymorphism of PmrA found in ZTA13/ 02182 does not match exactly the allelic variants detected previously in Salmonella (81R H and 81R C), 13 including the first ever found in a polymyxin-resistant bacteria, 4 it corresponds to a strictly conserved position of the protein. 13 In addition, the 161V G mutation of PmrB found in ZTA11/01748 is the same polymorphism selected in vitro by colistin in Salmonella.
12
Both mutations might affect phosphate transfer between the two components of the system since V161 is located in the kinase domain of PmrB, whereas R81 is in the phosphate acceptor domain of PmrA. 13 The other unique polymorphism found among PmrA sequences in this work, 39S I in the ZTA13/ 02182 E. coli isolate, affects a residue that is not strictly conserved during protein evolution and has not been detected by in vitro selection in Salmonella.
13
This contribution represents, to our knowledge, the first description of PmrAB polymorphisms in colistin-resistant strains of E. coli or any other enterobacteria isolated from the environment. Although the finding of only two colistin-resistant strains from animal samples (swine faeces), taken in different years (2011 and 2013), could be considered a rare event, the extensive use of colistin in animal production justifies the importance of surveying their appearance in nature, which could challenge the efficacy of polymyxins in controlling multidrug-resistant organisms.
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